APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis A Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hepatitis A Vaccine Industry Growth and Trends Forecast to 2032

26 December 202593 pages

Choose your research edition.

Industry ResearchHepatitis A Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis A Vaccine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis A Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis A Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hepatitis A Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis A Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepatitis A Vaccine include GSK, Zhejiang Pukang, Changchun Institute of Biological, IMBCAMS, Sanofi, Merck, Convac, Sinovac and KM Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hepatitis A Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatitis A Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatitis A Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatitis A Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepatitis A Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatitis A Vaccine Market by Company

GSK

Zhejiang Pukang

Changchun Institute of Biological

IMBCAMS

Sanofi

Merck

Convac

Sinovac

KM Biologics

Hepatitis A Vaccine Segment by Type

Inactivated Vaccine

Live Attenuated Vaccine

Hepatitis A Vaccine Segment by Application

Government Institution

Private Sector

Other

Hepatitis A Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepatitis A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inactivated Vaccine Table 2. Major Company of Live Attenuated Vaccine Table 3. Global Hepatitis A Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Hepatitis A Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hepatitis A Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Hepatitis A Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Hepatitis A Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Hepatitis A Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hepatitis A Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hepatitis A Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Hepatitis A Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hepatitis A Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Hepatitis A Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Hepatitis A Vaccine Industry Trends Table 25. Hepatitis A Vaccine Industry Drivers Table 26. Hepatitis A Vaccine Industry Opportunities and Challenges Table 27. Hepatitis A Vaccine Industry Restraints Table 28. Global Hepatitis A Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hepatitis A Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Hepatitis A Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Hepatitis A Vaccine Sales Share by Company (2021-2026) Table 32. Global Hepatitis A Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Hepatitis A Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hepatitis A Vaccine Major Company Production Sites and Headquarters Table 35. Global Hepatitis A Vaccine Company, Product Type & Application Table 36. Global Hepatitis A Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hepatitis A Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hepatitis A Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Hepatitis A Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hepatitis A Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hepatitis A Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Hepatitis A Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Hepatitis A Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Hepatitis A Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hepatitis A Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hepatitis A Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Hepatitis A Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Hepatitis A Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Hepatitis A Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hepatitis A Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Hepatitis A Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hepatitis A Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Hepatitis A Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hepatitis A Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hepatitis A Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Hepatitis A Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hepatitis A Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Hepatitis A Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Hepatitis A Vaccine Product Portfolio Table 75. GSK Recent Development Table 76. Zhejiang Pukang Company Information Table 77. Zhejiang Pukang Business Overview Table 78. Zhejiang Pukang Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Zhejiang Pukang Hepatitis A Vaccine Product Portfolio Table 80. Zhejiang Pukang Recent Development Table 81. Changchun Institute of Biological Company Information Table 82. Changchun Institute of Biological Business Overview Table 83. Changchun Institute of Biological Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio Table 85. Changchun Institute of Biological Recent Development Table 86. IMBCAMS Company Information Table 87. IMBCAMS Business Overview Table 88. IMBCAMS Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. IMBCAMS Hepatitis A Vaccine Product Portfolio Table 90. IMBCAMS Recent Development Table 91. Sanofi Company Information Table 92. Sanofi Business Overview Table 93. Sanofi Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Hepatitis A Vaccine Product Portfolio Table 95. Sanofi Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck Hepatitis A Vaccine Product Portfolio Table 100. Merck Recent Development Table 101. Convac Company Information Table 102. Convac Business Overview Table 103. Convac Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Convac Hepatitis A Vaccine Product Portfolio Table 105. Convac Recent Development Table 106. Sinovac Company Information Table 107. Sinovac Business Overview Table 108. Sinovac Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Sinovac Hepatitis A Vaccine Product Portfolio Table 110. Sinovac Recent Development Table 111. KM Biologics Company Information Table 112. KM Biologics Business Overview Table 113. KM Biologics Hepatitis A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. KM Biologics Hepatitis A Vaccine Product Portfolio Table 115. KM Biologics Recent Development Table 116. North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 118. North America Hepatitis A Vaccine Sales Market Share by Country (2021-2026) Table 119. North America Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Hepatitis A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Hepatitis A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Hepatitis A Vaccine Market Share by Country (2021-2026) Table 124. North America Hepatitis A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Hepatitis A Vaccine Market Share Forecast by Country (2027-2032) Table 126. Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 128. Europe Hepatitis A Vaccine Sales Market Share by Country (2021-2026) Table 129. Europe Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Hepatitis A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Hepatitis A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Hepatitis A Vaccine Market Share by Country (2021-2026) Table 134. Europe Hepatitis A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Hepatitis A Vaccine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Hepatitis A Vaccine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Hepatitis A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Hepatitis A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Hepatitis A Vaccine Market Share by Country (2021-2026) Table 144. Asia-Pacific Hepatitis A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Hepatitis A Vaccine Market Share Forecast by Country (2027-2032) Table 146. Latin America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Latin America Hepatitis A Vaccine Sales Market Share by Country (2021-2026) Table 149. Latin America Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Hepatitis A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Hepatitis A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Hepatitis A Vaccine Market Share by Country (2021-2026) Table 154. Latin America Hepatitis A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Hepatitis A Vaccine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Hepatitis A Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Hepatitis A Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Hepatitis A Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Hepatitis A Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Hepatitis A Vaccine Market Share by Country (2021-2026) Table 164. Middle East and Africa Hepatitis A Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Hepatitis A Vaccine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Hepatitis A Vaccine Distributors List Table 169. Hepatitis A Vaccine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Hepatitis A Vaccine Image Figure 2. Global Hepatitis A Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis A Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis A Vaccine Sales (2021-2032) & (K Units) Figure 5. Inactivated Vaccine Image Figure 6. Global Inactivated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Live Attenuated Vaccine Image Figure 8. Global Live Attenuated Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Hepatitis A Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hepatitis A Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Hepatitis A Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Hepatitis A Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Hepatitis A Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hepatitis A Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hepatitis A Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hepatitis A Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hepatitis A Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hepatitis A Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hepatitis A Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hepatitis A Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Government Institution Image Figure 24. Global Government Institution Sales YoY Growth (2021-2032) & (K Units) Figure 25. Private Sector Image Figure 26. Global Private Sector Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Hepatitis A Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Hepatitis A Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Hepatitis A Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Hepatitis A Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Hepatitis A Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Hepatitis A Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Hepatitis A Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Hepatitis A Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Hepatitis A Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Hepatitis A Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Hepatitis A Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Hepatitis A Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Hepatitis A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Hepatitis A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Hepatitis A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Hepatitis A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hepatitis A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Hepatitis A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hepatitis A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Hepatitis A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hepatitis A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Hepatitis A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hepatitis A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Hepatitis A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hepatitis A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Hepatitis A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hepatitis A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Hepatitis A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hepatitis A Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Hepatitis A Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hepatitis A Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Hepatitis A Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Hepatitis A Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Hepatitis A Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Live Attenuated Vaccine
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • GSK
  • Zhejiang Pukang
  • Changchun Institute of Biological
  • IMBCAMS
  • Sanofi
  • Merck
  • Convac
  • Sinovac
  • KM Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepatitis A Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepatitis A Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepatitis A Vaccine Market by Type
  6. 1.3.1 Inactivated Vaccine
  7. 1.3.2 Live Attenuated Vaccine
  8. 1.4 Global Hepatitis A Vaccine Market Size by Type
  9. 1.4.1 Global Hepatitis A Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hepatitis A Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hepatitis A Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hepatitis A Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hepatitis A Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hepatitis A Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepatitis A Vaccine Industry Trends
  2. 2.2 Hepatitis A Vaccine Industry Drivers
  3. 2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
  4. 2.4 Hepatitis A Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepatitis A Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepatitis A Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Hepatitis A Vaccine Price (2021-2026)
  4. 3.4 Global Hepatitis A Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis A Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Hepatitis A Vaccine Company, Product Type & Application
  7. 3.7 Global Hepatitis A Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis A Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis A Vaccine Tier 1, Tier 2, and Tier 3
4 Hepatitis A Vaccine Regional Status and Outlook
  1. 4.1 Global Hepatitis A Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepatitis A Vaccine Historic Market Size by Region
  3. 4.2.1 Global Hepatitis A Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepatitis A Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepatitis A Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Hepatitis A Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepatitis A Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepatitis A Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepatitis A Vaccine by Application
  1. 5.1 Hepatitis A Vaccine Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Hepatitis A Vaccine Market Size by Application
  6. 5.2.1 Global Hepatitis A Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hepatitis A Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hepatitis A Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hepatitis A Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hepatitis A Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hepatitis A Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hepatitis A Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hepatitis A Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Hepatitis A Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Zhejiang Pukang
  8. 6.2.1 Zhejiang Pukang Company Information
  9. 6.2.2 Zhejiang Pukang Business Overview
  10. 6.2.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
  12. 6.2.5 Zhejiang Pukang Recent Developments
  13. 6.3 Changchun Institute of Biological
  14. 6.3.1 Changchun Institute of Biological Company Information
  15. 6.3.2 Changchun Institute of Biological Business Overview
  16. 6.3.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
  18. 6.3.5 Changchun Institute of Biological Recent Developments
  19. 6.4 IMBCAMS
  20. 6.4.1 IMBCAMS Company Information
  21. 6.4.2 IMBCAMS Business Overview
  22. 6.4.3 IMBCAMS Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 IMBCAMS Hepatitis A Vaccine Product Portfolio
  24. 6.4.5 IMBCAMS Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Hepatitis A Vaccine Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck Hepatitis A Vaccine Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Convac
  38. 6.7.1 Convac Company Information
  39. 6.7.2 Convac Business Overview
  40. 6.7.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Convac Hepatitis A Vaccine Product Portfolio
  42. 6.7.5 Convac Recent Developments
  43. 6.8 Sinovac
  44. 6.8.1 Sinovac Company Information
  45. 6.8.2 Sinovac Business Overview
  46. 6.8.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sinovac Hepatitis A Vaccine Product Portfolio
  48. 6.8.5 Sinovac Recent Developments
  49. 6.9 KM Biologics
  50. 6.9.1 KM Biologics Company Information
  51. 6.9.2 KM Biologics Business Overview
  52. 6.9.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 KM Biologics Hepatitis A Vaccine Product Portfolio
  54. 6.9.5 KM Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Hepatitis A Vaccine Sales by Country
  2. 7.1.1 North America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepatitis A Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Hepatitis A Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepatitis A Vaccine Market Size by Country
  6. 7.2.1 North America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepatitis A Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepatitis A Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepatitis A Vaccine Sales by Country
  2. 8.1.1 Europe Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepatitis A Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepatitis A Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepatitis A Vaccine Market Size by Country
  6. 8.2.1 Europe Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepatitis A Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepatitis A Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepatitis A Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepatitis A Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepatitis A Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepatitis A Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepatitis A Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepatitis A Vaccine Sales by Country
  2. 10.1.1 South America Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepatitis A Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Hepatitis A Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepatitis A Vaccine Market Size by Country
  6. 10.2.1 South America Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepatitis A Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepatitis A Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepatitis A Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Hepatitis A Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepatitis A Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Hepatitis A Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepatitis A Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepatitis A Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepatitis A Vaccine Value Chain Analysis
  2. 12.1.1 Hepatitis A Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepatitis A Vaccine Production Mode & Process
  7. 12.2 Hepatitis A Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepatitis A Vaccine Distributors
  10. 12.2.3 Hepatitis A Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst